We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+13.71%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$75.7B
AUM Growth
+$6.94B
Cap. Flow
-$695M
Cap. Flow %
-0.92%
Top 10 Hldgs %
38.84%
Holding
852
New
205
Increased
261
Reduced
298
Closed
58

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$840M
2
DIS icon
Walt Disney
DIS
+$492M
3
BA icon
Boeing
BA
+$492M
4
SBUX icon
Starbucks
SBUX
+$276M
5
SLB icon
SLB Ltd
SLB
+$216M

Sector Composition

Rank Sector Weight
1 Technology 26.48%
2 Consumer Discretionary 16.31%
3 Communication Services 13.43%
4 Healthcare 12.88%
5 Industrials 11.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PH icon
76
Parker-Hannifin
PH
$135B
$85.8M 0.11%
315,083
-379
-0.1% -$93.9K
HALO icon
77
Halozyme
HALO
$12.3B
$84.8M 0.11%
1,985,026
+538,171
+37% +$19.3M
WLL
78
DELISTED
Whiting Petroleum Corporation
WLL
$84.5M 0.11%
3,378,621
-142,808
-4% -$2.87M
TREX icon
79
Trex
TREX
$4.92B
$80.6M 0.11%
963,223
+211,753
+28% +$16.2M
SLAB icon
80
Silicon Laboratories
SLAB
$7.22B
$80.6M 0.11%
633,228
+70,771
+13% +$7.97M
CTLT
81
DELISTED
CATALENT, INC.
CTLT
$80.4M 0.11%
772,674
+32,848
+4% +$3.18M
FOXF icon
82
Fox Factory Holding Corp
FOXF
$878M
$77.1M 0.1%
729,602
+13,373
+2% +$1.22M
RPD icon
83
Rapid7
RPD
$770M
$76.6M 0.1%
849,170
+47,162
+6% +$3.37M
INSP icon
84
Inspire Medical Systems
INSP
$1.77B
$74M 0.1%
393,416
-2,237
-0.6% -$366K
GLOB icon
85
Globant
GLOB
$1.61B
$73.5M 0.1%
337,626
-2,026
-0.6% -$392K
AMED
86
DELISTED
Amedisys
AMED
$72.6M 0.1%
247,550
-1,547
-0.6% -$397K
TXRH icon
87
Texas Roadhouse
TXRH
$13.5B
$72.2M 0.1%
923,154
+112,301
+14% +$8.36M
NTRA icon
88
Natera
NTRA
$46.2B
$72M 0.1%
723,062
-4,107
-0.6% -$343K
KRNT icon
89
Kornit Digital
KRNT
$791M
$69.1M 0.09%
774,720
-4,672
-0.6% -$359K
PCRX icon
90
Pacira BioSciences
PCRX
$1.01B
$67.9M 0.09%
1,134,353
+292,253
+35% +$17.1M
MSCI icon
91
MSCI
MSCI
$41.1B
$67.9M 0.09%
151,976
-17,663
-10% -$6.93M
NEO icon
92
NeoGenomics
NEO
$2.14B
$67.1M 0.09%
1,245,828
-7,087
-0.6% -$320K
MTSI icon
93
MACOM Technology Solutions
MTSI
$23.4B
$66.3M 0.09%
1,204,197
-6,864
-0.6% -$293K
VRNS icon
94
Varonis Systems
VRNS
$5.04B
$66.1M 0.09%
1,211,613
-7,602
-0.6% -$330K
FTDR icon
95
Frontdoor
FTDR
$6.16B
$65.2M 0.09%
1,298,664
+59,128
+5% +$2.7M
KTOS icon
96
Kratos Defense & Security Solutions
KTOS
$11.1B
$63.5M 0.08%
2,316,041
+242,766
+12% +$5.31M
FORM icon
97
FormFactor
FORM
$9.02B
$63.2M 0.08%
1,468,486
-8,521
-0.6% -$308K
SMPL icon
98
Simply Good Foods
SMPL
$976M
$63M 0.08%
2,008,445
+68,303
+4% +$1.59M
RP
99
DELISTED
RealPage, Inc.
RP
$62M 0.08%
710,799
+71,358
+11% +$4.68M
MRCY icon
100
Mercury Systems
MRCY
$6.57B
$61M 0.08%
692,730
+24,610
+4% +$1.87M

Similar funds

Loomis, Sayles & Company's Q4 2020 Portfolio in Review

As of Q4 2020, Loomis, Sayles & Company held 852 positions worth $75.7B, up 10% from $68.7B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Loomis, Sayles & Company's Q4 2020 filing shows 205 new, 261 increased, 298 reduced and 58 closed positions. Its largest new stake was TSMC: 1,053,323 shares worth $115M. The largest sale was Varian Medical Systems, Inc., an estimated $442M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q4 2020 buy was TSMC: 1,053,323 shares worth $115M.
  • Loomis, Sayles & Company added most to Novartis in Q4 2020, an estimated $840M increase.
  • Loomis, Sayles & Company's biggest Q4 2020 reduction was Varian Medical Systems, Inc., cutting an estimated $442M.
  • Loomis, Sayles & Company fully exited Palomar in Q4 2020, selling an estimated $64.4M.
  • Loomis, Sayles & Company's ten largest holdings make up 39% of its $75.7B portfolio in Q4 2020.
  • Loomis, Sayles & Company opened 205 new positions and closed 58 in Q4 2020.
  • Loomis, Sayles & Company's portfolio value rose 10% quarter-over-quarter to $75.7B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2020, filed 12 Feb 2021.